Journal
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
Volume 142, Issue -, Pages 102-109Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ecoenv.2017.03.042
Keywords
Fluoxetine; Daphnia magna; Bioconcentration; Biomarker
Categories
Funding
- Fundamental Research Funds for the Central Universities [JUSRP11714]
- National Special Project on Water Pollution Control and Management [2012ZX07503-002]
Ask authors/readers for more resources
The aim of this study was to evaluate the bioconcentration potential of fluoxetine and its biological effects in Daphnia magna. After 48 h of waterborne exposure, the bioconcentration of fluoxetine in D. magna was determined to be 460.61 and 174.41 L kg(-1) for nominal exposure concentrations of 0.5 and 5 mu g L-1, respectively. Moreover, various biological endpoints, including physiological responses (filtration and ingestion rates), enzymatic biomarkers related to neurotoxicity [acetylcholinesterase (AChE)] and antioxidant defense [superoxide dismutase (SOD)], and an oxidative stress damage marker [malondialdehyde (MDA)], were assessed. Fluoxetine exposure increased the filtration rate of daphnia, while the ingestion rate was not obviously modified. AChE activity was significantly inhibited, highlighting the neurotoxicity of fluoxetine on D. magna. However, with some alterations in the SOD activity and MDA content, no obvious oxidative damage was observed in D. magna exposed to fluoxetine at the tested concentrations. These results indicate that fluoxetine can be accumulated and consequently induce physiological and biochemical perturbations in D. magna.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available